NO20033697L - Substituerte propan-1,3-diamin-derivater og den farmasöytiske anvendelse derav - Google Patents
Substituerte propan-1,3-diamin-derivater og den farmasöytiske anvendelse deravInfo
- Publication number
- NO20033697L NO20033697L NO20033697A NO20033697A NO20033697L NO 20033697 L NO20033697 L NO 20033697L NO 20033697 A NO20033697 A NO 20033697A NO 20033697 A NO20033697 A NO 20033697A NO 20033697 L NO20033697 L NO 20033697L
- Authority
- NO
- Norway
- Prior art keywords
- pharmaceutical use
- diamine derivatives
- substituted propane
- propane
- substituted
- Prior art date
Links
- XFNJVJPLKCPIBV-UHFFFAOYSA-N trimethylenediamine Chemical class NCCCN XFNJVJPLKCPIBV-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/73—Unsubstituted amino or imino radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
- C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
- C07C211/27—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring having amino groups linked to the six-membered aromatic ring by saturated carbon chains
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/33—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C211/39—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton
- C07C211/40—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing only non-condensed rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
- C07C233/77—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
- C07C233/78—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Anesthesiology (AREA)
- Urology & Nephrology (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10108307A DE10108307A1 (de) | 2001-02-21 | 2001-02-21 | Substituierte Propan-1,3-diamin-Derivate |
| PCT/EP2002/001765 WO2002066432A1 (de) | 2001-02-21 | 2002-02-20 | Substituierte propan- 1,3-diamin-derivate und ihre pharmazeutische verwendung |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20033697D0 NO20033697D0 (no) | 2003-08-20 |
| NO20033697L true NO20033697L (no) | 2003-10-17 |
Family
ID=7674965
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20033697A NO20033697L (no) | 2001-02-21 | 2003-08-20 | Substituerte propan-1,3-diamin-derivater og den farmasöytiske anvendelse derav |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US7230018B2 (cs) |
| EP (1) | EP1363885B1 (cs) |
| JP (1) | JP4447837B2 (cs) |
| KR (1) | KR20030091995A (cs) |
| CN (1) | CN100434421C (cs) |
| AR (1) | AR035752A1 (cs) |
| AT (1) | ATE362916T1 (cs) |
| AU (1) | AU2002246095B2 (cs) |
| CA (1) | CA2438704C (cs) |
| CY (1) | CY1106711T1 (cs) |
| CZ (1) | CZ20031968A3 (cs) |
| DE (2) | DE10108307A1 (cs) |
| DK (1) | DK1363885T3 (cs) |
| EC (1) | ECSP034739A (cs) |
| ES (1) | ES2286240T3 (cs) |
| HU (1) | HUP0302746A3 (cs) |
| IL (2) | IL157494A0 (cs) |
| MX (1) | MXPA03006744A (cs) |
| NO (1) | NO20033697L (cs) |
| PE (1) | PE20021007A1 (cs) |
| PL (1) | PL372089A1 (cs) |
| PT (1) | PT1363885E (cs) |
| RU (1) | RU2003127397A (cs) |
| SI (1) | SI1363885T1 (cs) |
| SK (1) | SK286980B6 (cs) |
| WO (1) | WO2002066432A1 (cs) |
| ZA (1) | ZA200307321B (cs) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102005061428A1 (de) * | 2005-12-22 | 2007-08-16 | Grünenthal GmbH | Substituierte Cyclohexylmethyl-Derivate |
| ITMI20120536A1 (it) * | 2012-04-02 | 2013-10-03 | Carlo Angelo Ghisalberti | Composizioni per il trattamento dell¿incontinenza urinaria da stress in soggetti femminili |
| GB201601301D0 (en) * | 2016-01-25 | 2016-03-09 | Takeda Pharmaceutical | Novel compounds |
| CN110021156A (zh) * | 2018-01-10 | 2019-07-16 | 金宝电子工业股份有限公司 | 遥控系统以及遥控方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4017637A (en) * | 1973-03-26 | 1977-04-12 | American Home Products Corporation | Benzylamine analgesics |
| DE19915601A1 (de) * | 1999-04-07 | 2000-10-19 | Gruenenthal Gmbh | 3-Amino-3-arylpropan-1-ol-Derivate, deren Herstellung und Verwendung |
| DE19915602A1 (de) * | 1999-04-07 | 2000-10-19 | Gruenenthal Gmbh | 3-Amino-4-arylpropan-1-ol-Derivate, deren Herstellung und Verwendung |
-
2001
- 2001-02-21 DE DE10108307A patent/DE10108307A1/de not_active Withdrawn
-
2002
- 2002-02-19 AR ARP020100567A patent/AR035752A1/es not_active Application Discontinuation
- 2002-02-20 HU HU0302746A patent/HUP0302746A3/hu unknown
- 2002-02-20 DE DE50210197T patent/DE50210197D1/de not_active Expired - Lifetime
- 2002-02-20 JP JP2002565949A patent/JP4447837B2/ja not_active Expired - Fee Related
- 2002-02-20 WO PCT/EP2002/001765 patent/WO2002066432A1/de not_active Ceased
- 2002-02-20 AU AU2002246095A patent/AU2002246095B2/en not_active Ceased
- 2002-02-20 PE PE2002000142A patent/PE20021007A1/es not_active Application Discontinuation
- 2002-02-20 CZ CZ20031968A patent/CZ20031968A3/cs unknown
- 2002-02-20 PL PL02372089A patent/PL372089A1/xx not_active Application Discontinuation
- 2002-02-20 KR KR10-2003-7011008A patent/KR20030091995A/ko not_active Withdrawn
- 2002-02-20 CN CNB028052463A patent/CN100434421C/zh not_active Expired - Fee Related
- 2002-02-20 SK SK1030-2003A patent/SK286980B6/sk not_active IP Right Cessation
- 2002-02-20 MX MXPA03006744A patent/MXPA03006744A/es active IP Right Grant
- 2002-02-20 SI SI200230563T patent/SI1363885T1/sl unknown
- 2002-02-20 PT PT02714169T patent/PT1363885E/pt unknown
- 2002-02-20 ES ES02714169T patent/ES2286240T3/es not_active Expired - Lifetime
- 2002-02-20 DK DK02714169T patent/DK1363885T3/da active
- 2002-02-20 IL IL15749402A patent/IL157494A0/xx unknown
- 2002-02-20 RU RU2003127397/04A patent/RU2003127397A/ru not_active Application Discontinuation
- 2002-02-20 AT AT02714169T patent/ATE362916T1/de active
- 2002-02-20 CA CA2438704A patent/CA2438704C/en not_active Expired - Fee Related
- 2002-02-20 EP EP02714169A patent/EP1363885B1/de not_active Expired - Lifetime
-
2003
- 2003-08-20 IL IL157494A patent/IL157494A/en not_active IP Right Cessation
- 2003-08-20 EC EC2003004739A patent/ECSP034739A/es unknown
- 2003-08-20 NO NO20033697A patent/NO20033697L/no not_active Application Discontinuation
- 2003-08-21 US US10/644,981 patent/US7230018B2/en not_active Expired - Fee Related
- 2003-09-18 ZA ZA200307321A patent/ZA200307321B/en unknown
-
2007
- 2007-07-09 CY CY20071100903T patent/CY1106711T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20052855D0 (no) | Fosfonoksykinazolinderivater og farmasoytisk anvendelse derav. | |
| NO20042635L (no) | 5-Sulfanyl-ñH-1,2,4-triazol-derivater og deres anvendelse som medisin | |
| PL367532A1 (pl) | Pochodne diaminy | |
| NO20033384L (no) | Farmasoytisk formulering | |
| EE200300311A (et) | Ftalasinoon-piperidinoderivaadid, nende kasutamine ja ravim | |
| ATE370120T1 (de) | Substituierte 2-pyridin-cyclohexan-1,4- diaminderivate | |
| NO20033785L (no) | Farmasöytisk formulering | |
| NO20035627D0 (no) | Farmasöytisk formulering | |
| DK1513836T3 (da) | Piperazinylacylpiperidinderivater, fremstilling og terapeutisk anvendelse heraf | |
| DK1417189T3 (da) | Acylaminothiazolderivater, fremstilling og terapeutisk anvendelse heraf | |
| DK1202996T3 (da) | Titanforbindelser, fremstilling og anvendelse heraf | |
| DK1556382T3 (da) | 3-Phenylpyridoindolderivater, fremstilling og terapeutisk anvendelse deraf | |
| DE60114244D1 (de) | Osteosynthesevorrichtung | |
| NO20033120D0 (no) | 2-arylimino-2,3-dihydrotiazolderivater, fremgangsmater for fremstilling derav og terapeutisk anvendelse derav | |
| NO20033697D0 (no) | Substituerte propan-1,3-diamin-derivater og den farmasöytiske anvendelse derav | |
| IS2487B (is) | Asýloxýpýrrólidín afleiður, framleiðsla og meðferðarnotkun þar á | |
| AU2002246095A1 (en) | Substituted propane-1,3-diamine derivatives and the pharmaceutical use thereof | |
| EE200300563A (et) | Bensüülaminopürimidiiniühendid, nende kasutamine ja ravim | |
| DE50310743D1 (de) | Wässrige formulierungen von (2-hydroxymethyl-indanyl-4-oxy)-phenyl-4,4,4- trifluorbutan-1-sulfonat | |
| DE60228736D1 (de) | Menschliches bmcc1-gen | |
| IS7131A (is) | Nýjar 2,4-díamínóþíasól afleiður | |
| NO20041236L (no) | Farmasoytisk formulering | |
| IS7299A (is) | 3,4-díhýdró-1H-ísókínólóín-2-ýl-afleiður | |
| SE0103116D0 (sv) | Pharmaceutical combination | |
| NO20042856L (no) | Substituerte 2-tio-3,5-dicyano-4-fenyl-6-aminopyridiner og anvendelse av samme |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |